Zhuohao Liu

5PUBLICATIONS
25CO-AUTHORS
Molecular targetsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Medical devicesGene expression (incl. microarray and other genome-wide approaches)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Oct 05, 2026
Targeting SLC38A5 Overcomes αPD-1 Immunotherapy Resistance by Alleviating Glutamine Competition Between Glioblastoma Cells and T Cells.

|Mar 03, 2026
GITR activation potentiates anti-tumor immunity of tumor-infiltrating lymphocytes expanded from glioblastoma by rescuing exhaustion.

Jiayi Zhou, Yinggui Yang, Ran Ye

|Aug 14, 2024
ALOX5 contributes to glioma progression by promoting 5-HETE-mediated immunosuppressive M2 polarization and PD-L1 expression of glioma-associated microglia/macrophages.

Tao Chen, Jiangang Liu, Chenci Wang

|Dec 05, 2022
A Novel Tumor-Promoting Role for Nuclear Factor IX in Glioblastoma Is Mediated through Transcriptional Activation of GINS1.

Ruixiang Ge, Chenci Wang, Jiangang Liu

|Feb 13, 2021
miR-18a promotes glioblastoma development by down-regulating ALOXE3-mediated ferroptotic and anti-migration activities.

Xinzhi Yang, Jiangang Liu, Chenci Wang

Pageof 1

Frequent Collaborators

4 joint publications

Jie Mao

2 joint publications

Chenci Wang

2 joint publications

Dinglan Wu

1 joint publications

Ruixiang Ge